BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 4299217)

  • 1. Biochemical aspects of the hyperglycemic action of diazoxide.
    Senft G
    Ann N Y Acad Sci; 1968 Apr; 150(2):242-55. PubMed ID: 4299217
    [No Abstract]   [Full Text] [Related]  

  • 2. The action of diazoxide on insulin secretion, medullo-adrenal secretion, and the liberation of catecholamines.
    Loubatières A; Mariani MM; Alric R
    Ann N Y Acad Sci; 1968 Apr; 150(2):226-41. PubMed ID: 4875709
    [No Abstract]   [Full Text] [Related]  

  • 3. Mode of action of a diazoxide analog (A025). Its effects on insulin secretion.
    Grant AM; Basabe JC; Lopez NL; Krees SV; Wolff FW
    Diabetes; 1970 Sep; 19(9):630-8. PubMed ID: 4990295
    [No Abstract]   [Full Text] [Related]  

  • 4. Mechanism of diazoxide hyperglycemia in animals.
    Tabachnick II; Gulbenkian A
    Ann N Y Acad Sci; 1968 Apr; 150(2):204-18. PubMed ID: 4299216
    [No Abstract]   [Full Text] [Related]  

  • 5. Diazoxide-induced long-term hyperglycemia. I. Preservation of B-cell insulin-releasing capacity.
    Gomis R; Plaza C; Malaisse WJ
    Diabetes Res; 1988 Dec; 9(4):183-6. PubMed ID: 3073904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Further studies on diazoxide suppression of insulin release from abnormal and normal islet tissue in man.
    Fajans SS; Floyd JC; Thiffault CA; Knopf RF; Harrison TS; Conn JW
    Ann N Y Acad Sci; 1968 Apr; 150(2):261-80. PubMed ID: 4299219
    [No Abstract]   [Full Text] [Related]  

  • 7. The effects of diazoxide and benzothiadiazine diuretics upon phosphodiesterase.
    Moore PF
    Ann N Y Acad Sci; 1968 Apr; 150(2):256-60. PubMed ID: 4299218
    [No Abstract]   [Full Text] [Related]  

  • 8. Control of insulin secretion by catecholamines, stress, and the sympathetic nervous system.
    Porte D; Robertson RP
    Fed Proc; 1973 Jul; 32(7):1792-6. PubMed ID: 4352448
    [No Abstract]   [Full Text] [Related]  

  • 9. [Insulin secretion in vitro. II. Inhibition of glucose induced insulin release by diazoxide].
    Frerichs H; Gerber R; Creutzfeldt W
    Diabetologia; 1966 Dec; 2(4):269-76. PubMed ID: 4902707
    [No Abstract]   [Full Text] [Related]  

  • 10. [Inhibition of insulin secretion by alpha adrenergic stimulatory agents].
    Senft G; Sitt R; Losert W; Schultz G; Hoffmann M
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1968; 260(4):309-23. PubMed ID: 4300750
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies concerning the hyperglycemic effects of diazoxide and its mode of action.
    Yabo R; Viktora J; Staquet M; Wolff F
    Diabetes; 1965 Sep; 14(9):591-4. PubMed ID: 5318830
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of imidazole upon insulin secretion.
    Malaisse WJ; Malaisse-Lagae F
    Diabetes; 1968; 17():308. PubMed ID: 4297287
    [No Abstract]   [Full Text] [Related]  

  • 13. Diazoxide unmasks glucose inhibition of insulin release by counteracting entry of Ca2+.
    Bergsten P; Gylfe E; Wesslén N; Hellman B
    Am J Physiol; 1988 Oct; 255(4 Pt 1):E422-7. PubMed ID: 3052102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diazoxide.
    Br Med J; 1972 Nov; 4(5837):417-8. PubMed ID: 4344353
    [No Abstract]   [Full Text] [Related]  

  • 15. Diazoxide and the secretion of insulin.
    Nutr Rev; 1972 Aug; 30(8):194-8. PubMed ID: 4340200
    [No Abstract]   [Full Text] [Related]  

  • 16. Insulin secretory blockade by benzothiadiazines and catecholamines: reversal by sulfonylureas.
    Seltzer HS; Crout JR
    Ann N Y Acad Sci; 1968 Apr; 150(2):309-21. PubMed ID: 4875710
    [No Abstract]   [Full Text] [Related]  

  • 17. [Recent pharmacologic aspects of sulfamides modifying insulin secretion (hypoglycemic and hyperglycemic sulfamides)].
    Loubatiéres A; Mariani MM
    Actual Physiol Pathol (Paris); 1973; 4():237-66. PubMed ID: 4219256
    [No Abstract]   [Full Text] [Related]  

  • 18. The role of adenosine 3':5'-cyclic monophosphate in the regulation of insulin release by isolated rat islets of Langerhans.
    Montague W; Cook JR
    Biochem J; 1971 Mar; 122(1):115-20. PubMed ID: 4330960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diazoxide causes recovery of beta-cell glucose responsiveness in 90% pancreatectomized diabetic rats.
    Leahy JL; Bumbalo LM; Chen C
    Diabetes; 1994 Feb; 43(2):173-9. PubMed ID: 8288040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AO44: an improved hyperglycemic agent.
    Lopez N; Basabe J; Grant A; Krees S; Terry M; Viktora J; Wolff F
    Metabolism; 1971 Apr; 20(4):373-83. PubMed ID: 5550304
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.